Literature DB >> 12893066

Implication of brevetoxin B1 and PbTx-3 in neurotoxic shellfish poisoning in New Zealand by isolation and quantitative determination with liquid chromatography-tandem mass spectrometry.

Akira Nozawa1, Kuniro Tsuji, Hitoshi Ishida.   

Abstract

Brevetoxin B1 (BTX-B1) was isolated from Austrovenus stutchburyi following the 1992-1993 outbreak of neurotoxic shellfish poisoning (NSP) in New Zealand. We report here the first isolation of PbTx-3 from the same shellfish and the development of a procedure for quantitative determination of PbTx-3 and BTX-B1. PbTx-3 was isolated by chromatography on columns of SiO2, ODS, and LH-20, followed by reverse-phase HPLCs. In mass spectrometry (MS) with an electrospray ionization (ESI) interface operating in the positive or negative ion mode, the abundant protonated ion [M+H]+ of PbTx-3 (m/z 897) and the de-sodiated ion [M-Na]- of BTX-B1 (m/z 1016) were generated, respectively. These served as precursor ions for collision-induced dissociation, and the product ions of m/z 725 from PbTx-3 and m/z 80 from BTX-B1 were identified, allowing unambiguous confirmation of these toxins by selected reaction monitoring liquid chromatography-tandem mass spectrometry (SRM LC-MS/MS) analysis. The determination limits were 0.4 and 2 ng/g for BTX-B1 and PbTx-3 at a signal-to-noise ratio of five, respectively. This LC-MS/MS method was successfully applied to determine BTX-B1 and PbTx-3 in the NSP-associated toxic shellfish. BTX-B1 was found in both A. stutchburyi and Perna canaliculus, but not in Crassostrea gigas, while PbTx-3 was found in all three.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12893066     DOI: 10.1016/s0041-0101(03)00123-5

Source DB:  PubMed          Journal:  Toxicon        ISSN: 0041-0101            Impact factor:   3.033


  6 in total

1.  Review of Florida Red Tide and Human Health Effects.

Authors:  Lora E Fleming; Barbara Kirkpatrick; Lorraine C Backer; Cathy J Walsh; Kate Nierenberg; John Clark; Andrew Reich; Julie Hollenbeck; Janet Benson; Yung Sung Cheng; Jerome Naar; Richard Pierce; Andrea J Bourdelais; William M Abraham; Gary Kirkpatrick; Julia Zaias; Adam Wanner; Eliana Mendes; Stuart Shalat; Porter Hoagland; Wendy Stephan; Judy Bean; Sharon Watkins; Tainya Clarke; Margaret Byrne; Daniel G Baden
Journal:  Harmful Algae       Date:  2011-01-01       Impact factor: 4.273

2.  Use of biosensors as alternatives to current regulatory methods for marine biotoxins.

Authors:  Natalia Vilariño; Eva S Fonfría; M Carmen Louzao; Luis M Botana
Journal:  Sensors (Basel)       Date:  2009-11-24       Impact factor: 3.576

Review 3.  Potential threats posed by new or emerging marine biotoxins in UK waters and examination of detection methodology used in their control: brevetoxins.

Authors:  Andrew D Turner; Cowan Higgins; Keith Davidson; Andrea Veszelovszki; Daniel Payne; James Hungerford; Wendy Higman
Journal:  Mar Drugs       Date:  2015-03-12       Impact factor: 5.118

4.  Preparation of Monoclonal Antibody for Brevetoxin 1 and Development of Ic-ELISA and Colloidal Gold Strip to Detect Brevetoxin 1.

Authors:  Sumei Ling; Shiwei Xiao; Chengjie Xie; Rongzhi Wang; Linmao Zeng; Ke Wang; Danping Zhang; Xiulan Li; Shihua Wang
Journal:  Toxins (Basel)       Date:  2018-02-08       Impact factor: 4.546

Review 5.  Chemodiversity of Brevetoxins and Other Potentially Toxic Metabolites Produced by Karenia spp. and Their Metabolic Products in Marine Organisms.

Authors:  Vincent Hort; Eric Abadie; Nathalie Arnich; Marie-Yasmine Dechraoui Bottein; Zouher Amzil
Journal:  Mar Drugs       Date:  2021-11-24       Impact factor: 5.118

6.  Guidance Level for Brevetoxins in French Shellfish.

Authors:  Nathalie Arnich; Eric Abadie; Zouher Amzil; Marie-Yasmine Dechraoui Bottein; Katia Comte; Estelle Chaix; Nicolas Delcourt; Vincent Hort; César Mattei; Jordi Molgó; Raphaele Le Garrec
Journal:  Mar Drugs       Date:  2021-09-15       Impact factor: 5.118

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.